You are here

US WorldMeds

US WorldMeds' Iwilfin bags FDA nod as 1st oral maintenance treatment for high-risk neuroblastoma

Fierce Pharma

Thu, 12/14/23 - 10:52 pm

FDA adcomm backs US WorldMeds’ potential high-risk pediatric neuroblastoma drug

Medical Marketing and Media

Thu, 10/5/23 - 11:33 am

pediatric neuroblastoma

clinical trials

Supernus Makes a Parkinson’s Play With $300M Deal for US WorldMeds Drugs

Xconomy

Wed, 04/29/20 - 10:43 pm

Supernus Pharmaceuticals

Salix, US WorldMeds eye 2019 push into the mainstream for opioid withdrawal drug Lucemyra

Fierce Pharma

Mon, 08/13/18 - 10:56 am

opioid withdrawal

Valeant signs with WorldMeds to hawk first-ever opioid withdrawal drug Lucemyra

Fierce Pharma

Thu, 06/28/18 - 07:06 pm

opioid withdrawal

Valeant Pharmaceuticals

In a first, FDA approves drug meant to mitigate symptoms of opioid withdrawal

Stat

Wed, 05/16/18 - 10:51 pm

opioid withdrawal